Stock listing
NASDAQ:ALBO Albireo Pharma Inc Stock
Follow Albireo Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:ALBO
$44.15 USD
Close on Mar 2, 2023 · No longer trades
- Lowest – highest close
- $11.67 – $44.95 USDSince Nov 4, 2016 · lowest Mar 16, 2020 · highest Feb 3, 2023
Delisted NASDAQ:ALBO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ALBO
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Albireo Pharma Inc on 6ix
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 8, 2022
- Decks
- 8 decks · latest Oct 11, 2022
Events
| Call | When | Status |
|---|---|---|
| Albireo Pharma (ALBO) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 4:30 PM ET | Replay |
| Albireo Pharma (ALBO) Q2 2022 Earnings Call | Mon, Aug 15, 2022 · 4:30 PM ET | Replay |
| Albireo Pharma (ALBO) Q1 2022 Earnings Call | Mon, May 16, 2022 · 4:30 PM ET | Replay |
| Albireo Pharma (ALBO) Q4 2021 Earnings Call | Tue, Mar 01, 2022 · 10:00 AM ET | Replay |
| Albireo Pharma (ALBO) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 10:00 AM ET | Replay |
| Albireo Pharma (ALBO) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 10:00 AM ET | Replay |
| Albireo Pharma (ALBO) Q1 2021 Earnings Call | Thu, May 06, 2021 · 10:00 AM ET | Replay |
| Albireo Pharma (ALBO) Q4 2020 Earnings Call | Thu, Feb 25, 2021 · 10:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (October 2022) | Corporate update | 18 slides | Oct 11, 2022 |
| Investor Presentation (December 2016) | Investor deck | 40 slides | Dec 21, 2016 |
| Biodel — Merger or Acquisition (October 2016) | Merger or acquisition | 49 slides | Oct 11, 2016 |
| Biodel — Merger or Acquisition (October 2016) | Merger or acquisition | 43 slides | Oct 11, 2016 |
| Biodel — Merger or Acquisition (September 2016) | Merger or acquisition | 45 slides | Sep 22, 2016 |
| Biodel — Merger or Acquisition (May 2016) | Merger or acquisition | 41 slides | May 25, 2016 |
| Biodel — Technical Presentation (March 2015) | Technical | 12 slides | Mar 16, 2015 |
| Biodel — Investor Presentation (October 2014) | Investor deck | 42 slides | Oct 27, 2014 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Habib Joseph Dable Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Acceleron Pharma Inc (CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past) | Director · Aug 8, 2022 – Mar 2, 2023 · Past |
| Heather Preston Other companies: Oxford Nanopore Technologies PLC (Non Executive Director · Since at least May 1, 2026); Aligos Therapeutics, Inc. (Director · Since at least Aug 7, 2024); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Fusion Pharmaceuticals Inc (Director · Jun 25, 2020 – Jun 14, 2023 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Jun 24, 2021 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jun 19, 2019 · Past); Otonomy Inc (Director · Aug 12, 2014 – Jun 11, 2019 · Past); Alder BioPharmaceuticals Inc (Director · May 7, 2014 – Oct 22, 2019 · Past) | Director · Nov 3, 2016 – Jan 23, 2017 · Past |
| Charles A Sanders Other companies: LipoScience Inc (Director · Jan 24, 2013 – Jan 30, 2013 · Past); BioCryst Pharmaceuticals, Inc. (Director · Dec 8, 2009 – Feb 29, 2016 · Past); Cephalon Inc (Director · May 12, 2009 – May 20, 2010 · Past); Vertex Pharmaceuticals Incorporated (Director · May 4, 2009 – Jun 1, 2010 · Past); Genentech Inc (Director · Mar 26, 2009 – Mar 26, 2009 · Past); Icagen Inc (Director · Mar 5, 2009 – Sep 2, 2011 · Past) | Director · Mar 3, 2009 – Mar 8, 2012 · Past |
| Pamela Stephenson Other companies: Disc Medicine, Inc. (Chief Commercial Officer · Since at least Feb 26, 2024); Zynerba Pharmaceuticals Inc (Director · Jun 14, 2022 – Oct 10, 2023 · Past) | Chief Commercial Officer · Apr 22, 2022 – Mar 2, 2023 · Past |
| Patrick Taylor Horn Other companies: Fulcrum Therapeutics, Inc. (Chief Medical Officer · Mar 18, 2024 – Mar 18, 2024 · Past); Tetraphase Pharmaceuticals Inc (Chief Medical Officer · May 15, 2013 – Jun 13, 2017 · Past) | Chief Medical Officer · Aug 6, 2018 – Oct 22, 2021 · Past |
| Craig Hopkinson Other companies: Alkermes plc (Executive Vice President, Research & Development and Chief Medical Officer · Since at least Jun 7, 2019) | Director · Dec 1, 2022 – Mar 2, 2023 · Past |
| Jason Duncan Other companies: Neumora Therapeutics, Inc. (See Remarks · Since at least Dec 11, 2023) | Chief Legal Officer and GC · Jun 4, 2018 – Mar 2, 2023 · Past |
| Julia R Brown Other companies: Gyre Therapeutics, Inc. (Director · May 12, 2010 – Aug 14, 2015 · Past) | Director · Apr 24, 2012 – Jun 7, 2018 · Past |
| Martha J Carter Other companies: Aegerion Pharmaceuticals Inc (See Remarks · Aug 4, 2015 – May 9, 2016 · Past) | Chief Regulatory Officer · Nov 28, 2016 – Mar 2, 2023 · Past |
| Peter A Zorn Other companies: Gyre Therapeutics, Inc. (SVP, Lgl Affrs, GC & Secretary · Dec 19, 2007 – Jan 17, 2013 · Past) | Chief Corp. Officer, GC & Sec · Nov 3, 2016 – Aug 21, 2017 · Past |
All 15 people
| Person | Seat |
|---|---|
| Anne Klibanski | Director · Jun 8, 2018 – Jun 24, 2021 · Past |
| Barry H Ginsberg | Director · Jun 11, 2008 – Feb 24, 2016 · Past |
| Erik Steiner | Vice-President, Operations · Dec 14, 2010 – Dec 23, 2013 · Past |
| Jan Mattsson | Chief Scientific Officer · Nov 3, 2016 – Mar 2, 2023 · Past |
| Susan Alesina | Director · Aug 8, 2022 – Mar 2, 2023 · Past |
Log in to ask 6ix AI your own questions about Albireo Pharma Inc.